Dr. Ai on Potential With Mogamulizumab in CTCL
3 Görünümler
• 08/09/23
0
0
gömmek
administrator
Aboneler
Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar